Study to Evaluate the Efficacy and Safety of BGB-11417 in Participants With Waldenstr öm's Macroglobulinemia

Conditions:   Waldenstrom Macroglobulinemia;   Waldenstrom's Macroglobulinemia Recurrent;   Waldenstrom's Macroglobulinemia Refractory Intervention:   Drug: BGB-11417 Sponsor:   BeiGene Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials